Our research

Pharmacoepidemiology emerged as a research topic in the early 1960s after the side effect disaster surrounding the drug thalidomide (Neurosedyn) and alarm reports about poor quality and high costs for medicines when used in healthcare. Since then, there has been a rapid development. Today, the discipline includes analyses of how drugs are prescribed and used as well as studies of benefits and side effects with the drug treatment. There is an increased drug consumption in society and a greater focus on sustainable drug use socially, economically and ecologically. Consequently, pharmacoepidemiology is a research area in rapid expansion. More about the science and its future can be found in a theme issue of SVEPET (2019 nr 4 (text in Swedish)) and the article Intriguing Future of Pharmacoepidemiology (National Library of Medicine).

Our research focuses on four main areas

•  Adherence to drug treatment
•  Treatment of cardiovascular diseases
•  Pharmacoepidemiology and COVID-19
•  Medicines in the environment